Stocktoria
BiomX Inc. PHGE
NYSE American · XASE · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-12-18
BiomX Inc. statistics & valuation
Market cap$4.2M
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
P / E vs its own history
BiomX Inc. trades at about 0× earnings — below its 10-year norm (10-year range 0.2×–207.8×, median 8.9×).
0.2×
207.8×
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| Return on assets | -626.0% | -41.0% | -104.6% | -62.2% | -46.4% | -42.8% | -22.3% | 0.5% | -28.1% |
| Return on equity | 2780.3% | -73.4% | -849.4% | -134.6% | -76.2% | -52.4% | -24.3% | 0.9% | -29.7% |
| Debt / equity | — | — | 3.63× | 0.71× | 0.32× | — | — | — | — |
| Current ratio | 0.87 | 2.48 | 1.58 | 4.65 | 6.03 | 8.47 | 13.58 | 1.98 | 24.34 |
Source: SEC EDGAR filings · CIK 0001739174 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.